Search research articles
Contact Us
Filters
Showing results (1-10 of 70) with videos related to
Page
of 7
Sort By:
Therapeutic Innovation & Regulatory Science
|
June 20, 2020
New FDA Guidance on General Clinical Trial Conduct in the Era of COVID-19
J Rick Turner
Therapeutic Innovation & Regulatory Science
|
September 19, 2018
Update From the Field of Renal Sympathetic Denervation: A Focus on Safety Nomenclature Considerations
J Rick Turner
Journal of Clinical Hypertension (Greenwich, Conn.)
|
August 24, 2017
Can clinical practice learn about measuring blood pressure from our veterinary colleagues?
J Rick Turner
Therapeutic Innovation & Regulatory Science
|
October 21, 2020
FDA's New Guidance for Industry Addressing Evaluation of the Safety of New Drugs for Improving Glycemic Control: A Case Study in Regulatory Science
J Rick Turner
Therapeutic Innovation & Regulatory Science
|
February 22, 2019
The Role of Worst-Case Scenarios in Sponsors' and Regulators' Decision Making
J Rick Turner
Expert Opinion on Drug Safety
|
March 8, 2017
Integrated cardiovascular safety: multifaceted considerations in drug development and therapeutic use
J Rick Turner
Journal of Clinical Hypertension (Greenwich, Conn.)
|
November 7, 2012
The 50th anniversary of the Kefauver-Harris Amendments: efficacy assessment and the randomized clinical trial
J Rick Turner
Therapeutic Innovation & Regulatory Science
|
September 12, 2018
Proposed Proarrhythmic Cardiac Safety Education in Medical, Pharmacy, and Nursing Schools: An Interprofessional Model
J Rick Turner
Therapeutic Innovation & Regulatory Science
|
May 2, 2018
Reporting of Randomized Clinical Trials Remains Far from Optimal
J Rick Turner
Therapeutic Innovation & Regulatory Science
|
May 4, 2018
A Milestone: Therapeutic Innovation & Regulatory Science Has Been Accepted for Inclusion in MEDLINE
J Rick Turner
Page
of 7
Search research articles
Search
Showing results (1-10 of 70) with videos related to
Sort By:
Page
of 7
Therapeutic Innovation & Regulatory Science
|
June 20, 2020
New FDA Guidance on General Clinical Trial Conduct in the Era of COVID-19
J Rick Turner
Therapeutic Innovation & Regulatory Science
|
September 19, 2018
Update From the Field of Renal Sympathetic Denervation: A Focus on Safety Nomenclature Considerations
J Rick Turner
Journal of Clinical Hypertension (Greenwich, Conn.)
|
August 24, 2017
Can clinical practice learn about measuring blood pressure from our veterinary colleagues?
J Rick Turner
Therapeutic Innovation & Regulatory Science
|
October 21, 2020
FDA's New Guidance for Industry Addressing Evaluation of the Safety of New Drugs for Improving Glycemic Control: A Case Study in Regulatory Science
J Rick Turner
Therapeutic Innovation & Regulatory Science
|
February 22, 2019
The Role of Worst-Case Scenarios in Sponsors' and Regulators' Decision Making
J Rick Turner
Expert Opinion on Drug Safety
|
March 8, 2017
Integrated cardiovascular safety: multifaceted considerations in drug development and therapeutic use
J Rick Turner
Journal of Clinical Hypertension (Greenwich, Conn.)
|
November 7, 2012
The 50th anniversary of the Kefauver-Harris Amendments: efficacy assessment and the randomized clinical trial
J Rick Turner
Therapeutic Innovation & Regulatory Science
|
September 12, 2018
Proposed Proarrhythmic Cardiac Safety Education in Medical, Pharmacy, and Nursing Schools: An Interprofessional Model
J Rick Turner
Therapeutic Innovation & Regulatory Science
|
May 2, 2018
Reporting of Randomized Clinical Trials Remains Far from Optimal
J Rick Turner
Therapeutic Innovation & Regulatory Science
|
May 4, 2018
A Milestone: Therapeutic Innovation & Regulatory Science Has Been Accepted for Inclusion in MEDLINE
J Rick Turner
Page
of 7